Oleuropein mitigates non‐alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high‐fat diet‐induced obese mice via activating PPARα

Documents similaires

• 5‐Heptadecylresorcinol ameliorates high‐fat diet induced non‐alcoholic fatty liver disease through modulating bile acid profile and suppressing inflammation
  par: Zihui Yang, et autres
  Publié: (2025)
• Walnut‐derived peptides combined with intermittent fasting alleviated obesity by modulating gut microbiota and liver metabolome in high‐fat‐diet‐induced obesity mice
  par: Jing Li, et autres
  Publié: (2025)
• Untargeted metabolomics analysis of probiotic jujube juice and its anti‐obesity effects on high‐fat‐diet‐induced obese mice
  par: Meixue Pu, et autres
  Publié: (2024)
• Persimmon carotenoid extract rich in β‐cryptoxanthin improves glucose homeostasis and reduces liver damage in high‐fat‐diet‐induced type 2 diabetic and metabolic dysfunction‐associated steatotic liver disease mice
  par: Bryan Moreno‐Chamba, et autres
  Publié: (2025)
• Maslinic acid alleviates alcoholic liver injury in mice and regulates intestinal microbiota via the gut–liver axis
  par: Jingwen Su, et autres
  Publié: (2024)